Beta vulgaris ‐derived exosome‐like nanovesicles alleviate chronic doxorubicin‐induced cardiotoxicity by inhibiting ferroptosis
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Jiejie Cai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Beta vulgaris, Exosomes, Ferroptosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Science and Technology Planning Project of Wenzhou Science & Technology Bureau of Zhejiang Province of China, Key Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Provincial of China, Zhejiang Engineering Research Center for Hospital Emergency and Process Digitization of Zhejiang Province of China.
Abstract (Originalsprache)
Dose‐dependent heart failure is a major complication of the clinical use of doxorubicin (Dox), one of the most potent chemotherapeutic agents. Effective adjuvant therapy is required to prevent Dox‐induced cardiotoxicity. Currently, plant‐derived exosome‐like nanovesicle (PELNV) has revealed their salubrious antioxidant and immunological regulating actions in various disease models. In this study, we isolated, purified and characterized Beta vulgaris ‐derived exosome‐like nanovesicle (BELNV). Dox or normal saline was given to HL‐1 cells (3 μM) and 8‐week C57BL/6N mice (5 mg/kg bodyweight per week for 4 weeks) to establish the in vitro and in vivo model of Dox‐induced cardiotoxicity. Administration of BELNV significantly alleviated chronic Dox‐induced cardiotoxicity in terms of echocardiographic and histological results. A reduced malondialdehyde (MDA), increased ratio of glutathione (GSH) to oxidized glutathione (GSSG) and levels of system xc − and glutathione peroxidase 4 were observed, indicating that DOX‐stimulated ferroptosis was reversed by BELNV. Besides, the safety of BELNV was also validated since no liver, spleen, and kidney toxicity induced by BELNV was observed. These findings provide evidence that BELNV may act as a novel therapeutic biomaterial for patients undergoing adverse effects of Dox, at least partly mediated by inhibiting Dox‐induced ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Förderung
- Science and Technology Planning Project of Wenzhou Science & Technology Bureau of Zhejiang Province of China
- Key Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Provincial of China
- Zhejiang Engineering Research Center for Hospital Emergency and Process Digitization of Zhejiang Province of China
Zitieren
APA
Cai, J., & Pan, J. (2024). Beta vulgaris ‐derived exosome‐like nanovesicles alleviate chronic doxorubicin‐induced cardiotoxicity by inhibiting ferroptosis. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23540
Vancouver
Cai J, Pan J. Beta vulgaris ‐derived exosome‐like nanovesicles alleviate chronic doxorubicin‐induced cardiotoxicity by inhibiting ferroptosis. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23540
BibTeX
@article{Cai2024,
author = {Cai, Jiejie and Pan, Jingye},
title = {Beta vulgaris ‐derived exosome‐like nanovesicles alleviate chronic doxorubicin‐induced cardiotoxicity by inhibiting ferroptosis},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23540}
}
EUVIMED